On June 13, 2013, the U.S. Supreme Court ruled in a major case that invalidates patents on two genes associated with hereditary breast and ovarian cancer. The case was brought by Professor Dan Ravicher of Cardozo School of Law, along with the ACLU.
Here, Cardozo's Professor Michael Burstein discusses this recent decision against Myriad Genetics and gene patenting.